Vial is a hyper scalable biotech — advancing programs into the clinic with lower cost trials and computationally designed therapeutics.
Vial has raised $67.0M in total funding. The most recent round was Series B. The last funding was announced in November 2022.
Vial's investors include General Catalyst, BoxGroup, Buckley Ventures, ATEL Ventures, Josh Buckley.
Vial is headquartered in San Francisco, United States.
Vial is a hyper scalable biotech — advancing programs into the clinic with lower cost trials and computationally designed therapeutics.
Vial is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vial — Funding & Investors." VCBacked, November 30, 2022, https://www.vcbacked.co/company/vial. Accessed September 15, 2026.
VCBacked. (2022). Vial — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/vial
{{cite web |title=Vial — Funding & Investors |url=https://www.vcbacked.co/company/vial |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated